RxDoctor Payments DataLook up a doctor →

Eleonora Teplinsky, MD

Hematology & Oncology · Paramus, NJNPI 1477781474

Payments from drug & device makers

$2,642,786in general payments, 2019–2025

Across 402 payments — averaging $6574.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.8M
  • Eli Lilly$263K
  • Pfizer$232K
  • AbbVie$75K
  • AstraZeneca$63K
  • Sanofi US Services Inc.$53K
  • plus $196K from 13 others
$846in research payments, 2019–2025

Across 1 payment — averaging $846.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$846

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis19$1,761,038
Eli Lilly19$263,272
Pfizer182$232,046
AbbVie10$75,105
AstraZeneca19$63,110
Sanofi US Services Inc.25$52,568
Daiichi Sankyo Inc.56$48,960
Genentech, Inc.20$47,306
Astrazeneca UK Limited9$32,975
Novocure Inc.5$24,478
Merck7$20,941
Immunogen, Inc.2$16,515
Eisai Inc.2$2,175
Tesaro, Inc.4$1,795
Johnson & Johnson16$203
Gilead4$170
Medtronic1$96
Amgen1$17
E.r. Squibb & Sons, L.L.C.1$15

How this compares

$2,642,786 in reported general payments places this provider in the 95th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey

Medicare billing

Part B allowed, 2024
$177,918
Medicare patients
435
Services billed
2,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Paramus

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →